Featured Partnerships

Tara Health and a collaborative of leading reproductive health foundations and investors engaged the Camber Collective to map the landscape of the U.S. reproductive health market. We commissioned a report to better understand the sector’s most pressing needs and to identify areas for investment across asset classes that have a high potential to improve access to and quality of reproductive health products and services. See the link to the report below.

Tara Health and the Foust/Meeker Team at Merrill Lynch have partnered to build a portfolio that is 100-percent aligned with the foundation’s mission. The portfolio comprises diverse asset classes, including public and private fixed income, public equities, mission-related hedge funds and private equity. Some of the investment management companies in the portfolio include Calvert, PAX World Investments, Neuberger Berman Funds, Wasmer, Schroeder & Company, Breckinridge Capital Advisors, TIAA Cref Global Asset Management and Ariel Asset Management. The Foust/Meeker Team at Merrill Lynch includes Mary K. Foust, Senior Vice President of Wealth Management, and Alena M. Meeker, First Vice President of Wealth Management.

Tara Health has partnered with Genentech to launch a multi-year research collaborative that will address innovative approaches to reducing long-term chronic disease. The collaborative includes the Center for Youth Wellness, the UCSF Benioff Children’s Hospital Oakland and the Bio-Core Bank at the University of California, San Francisco. This project will culminate in a randomized control trial to test and validate a screening tool for Adverse Childhood Experiences (ACE) in children. The study will also evaluate two separate primary care-based interventions and a panel of bio-markers, for children exposed to toxic stress. The study will help determine the potential impact of ACE screening on decreasing the risks for long-term chronic disease. 

Ideas & Resources

Tara Health is proud to support research and evidence-based best practices. Below are three reports that we supported in 2017.

    The U.S. Reproductive Health Investment Case was commissioned by the Reproductive Health Investors Alliance Steering Committee. It is dedicated to increasing the total amount of philanthropy and impact investment directed toward high-impact opportunities that increase American women’s ability to manage their fertility in a safe and dignified manner. The report includes a detailed landscape analysis of reproductive health needs in the U.S., a systems view of the actors and issues that affect access to high quality contraception & abortion services, and a set of strategic investment opportunities. Read more.

    Download Report

    The Center for High Impact Philanthropy (CHIP), with the support of Tara Health, released The XX Factor in 2017. The report examines the inequalities and opportunities afforded to women and girls and provides the first comprehensive and evidence-based framework to help funders take action. The framework identifies the five dimensions of a woman’s life that are critical to her flourishing: Economic Empowerment, Education, Health, Legal Rights, and Personal Safety. The framework also identifies outcome measures that mark progress in women’s lives and the evidence-based strategies that work to improve those measures.

    Download Report

    As recently as five years ago, there were few options for structured venture capital and debt vehicles moving capital with a gender lens. Interested investors had little access to or knowledge of the key players, vehicles and opportunities in this burgeoning field of finance. Tara Health was pleased to support Project Sage: Tracking Venture Capital with a Gender Lens, authored by Suzanne Biegel, Sandra M. Hunt, and Sherryl Kuhlman as part of the Wharton Social Impact Initiative at the University of Pennsylvania. The report maps funds and provides a point-in-time look at private equity and debt funds that publicly state the use of a gender lens. 

    Download Report

    An early release of the U.S. Reproductive Health Investment Case was shared with 75+ national experts, in reproductive health and impact investing, at a day-long convening in October of 2017 in San Francisco. View a slideshow of photos from the event.

    Connect with us on Social Media